Stock 300149 CHEMPARTNER PHARMATECH CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Chempartner Pharmatech Co., Ltd.

Equities

300149

CNE100000Y27

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
5.27 CNY +1.74% Intraday chart for Chempartner Pharmatech Co., Ltd. +19.23% -31.11%
Apr. 25 Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 25 Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Chempartner Pharmatech Announces Resolutions of the The First Extraordinary General Meeting of Shareholders 2024.
CI
MEGA STAR CENTRE LIMITED Announces Nominee to the Board of Chempartner Pharmatech.
CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
ChemPartner PharmaTech CFO Steps Down
MT
Chempartner Pharmatech Co., Ltd.(XSEC:300149) added to S&P Global BMI Index
CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Chempartner Pharmatech Co., Ltd.(XSEC:300149) dropped from S&P Global BMI Index
CI
Chinese Shares End Mixed; ChemPartner Falls 6% as Chairman Assumes CEO Role
MT
ChemPartner PharmaTech Appoints Chairman as CEO; Shares Rise 4%
MT
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Tate & Lyle Investments Limited completed the acquisition of Quantum Hi-Tech Biological Co., Ltd. from Chempartner Pharmatech Co., Ltd..
CI
Chempartner Pharmatech Co., Ltd. announced that it expects to receive CNY 300 million in funding
CI
Jiangmen Xinhui Hefeng Trading Co., Ltd. completed the acquisition of Quantum Hi-Tech Health Technology Co., Ltd from Chempartner Pharmatech Co., Ltd..
CI
Chempartner Pharmatech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Tate & Lyle To Pay $237 Million For Chinese Prebiotic Dietary Fiber Business
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300149 Stock
  4. News Chempartner Pharmatech Co., Ltd.